Research Topics
Genomes and GenesSpecies | I SchweitzerSummaryAffiliation: University of Melbourne Country: Australia Publications
| Collaborators
|
Detail Information
Publications
Risk of adverse events with the use of augmentation therapy for the treatment of resistant depressionI Schweitzer
University of Melbourne and Professional Unit, The Melbourne Clinic, Richmond, Victoria, Australia
Drug Saf 19:455-64. 1998..Considerable caution should be exercised when combining psychotropic drugs. The practitioner should only do so with a full knowledge of the compounds involved and their pharmacological properties...- Does risperidone have a place in the treatment of nonschizophrenic patients?I Schweitzer
Department of Psychiatry, University of Melbourne, Victoria, Australia
Int Clin Psychopharmacol 16:1-19. 2001..This article reviews the evidence that risperidone may be an effective new treatment for disorders other than schizophrenia... - Sustained response to open-label venlafaxine in drug-resistant major depressionI Schweitzer
Department of Psychiatry, University of Melbourne, and The Melbourne Clinic, Victoria, Australia
J Clin Psychopharmacol 21:185-9. 2001..Patients with resistant depression that was treated with venlafaxine maintained their response for up to 10 months after an 8-week phase of treatment and showed some evidence of further improvement... - Antiglaucoma medication and clinical depressionI Schweitzer
Department of Psychiatry, The Melbourne Clinic, University of Melbourne, 130 Church Street, Richmond, Victoria 3121, Australia
Aust N Z J Psychiatry 35:569-71. 2001..The aim of this paper is to alert the medical community to the potential risk of clinical depression following the use of antiglaucoma medication... - Is late onset depression a prodrome to dementia?Isaac Schweitzer
Department of Psychiatry, University of Melbourne, Australia
Int J Geriatr Psychiatry 17:997-1005. 2002..Recent research suggests there are clinical and biological differences between late onset depression (LOD) and early-onset depression (EOD)... - Structural neuroimaging studies in late-life depression: a reviewI Schweitzer
Department of Psychiatry, University of Melbourne, Australia
World J Biol Psychiatry 2:83-8. 2001..Preliminary work suggests that these changes may be associated with a poor prognosis but there is a dearth of systematic, well-controlled longitudinal studies... 
Does a medicinal dose of kava impair driving? A randomized, placebo-controlled, double-blind studyJ Sarris
The University of Melbourne, Department of Psychiatry, Richmond, Melbourne, Victoria, Australia
Traffic Inj Prev 14:13-7. 2013..To date no controlled study has tested a medicinal dose of kava versus placebo and a standard sedative drug on driving ability and driving safety...- Evaluating complex, collaborative programmes: the Partnership Project as a case studyJ Pirkis
Program Evaluation Unit, Centre for Health Program Evaluation, University of Melbourne, PO Box 477, West Heidelberg, Victoria 3081, Australia
Aust N Z J Psychiatry 35:639-46. 2001..This paper illustrates a conceptual framework for developing, implementing and evaluating programmes concerned with linkages... - St John's wort (Hypericum perforatum) versus sertraline and placebo in major depressive disorder: continuation data from a 26-week RCTJ Sarris
Department of Psychiatry, The University of Melbourne, Melbourne, Australia
Pharmacopsychiatry 45:275-8. 2012..While the continuation data revealed an equivocal outcome between treatments at week 26, both SJW and sertraline were still therapeutically effective, with a pronounced "placebo-effect" impeding a significant result at week 26... - Should bipolar disorder be viewed as manic disorder? Implications for bipolar depressionI Schweitzer
The Melbourne Clinic, Department of Psychiatry, University of Melbourne, Richmond, Vic, Australia
Bipolar Disord 7:418-23. 2005..The paper also reviews diagnostic issues relating to bipolar depression. A broader approach may extend therapeutic choices, and open innovative research avenues... 
Complementary medicine, exercise, meditation, diet, and lifestyle modification for anxiety disorders: a review of current evidenceJ Sarris
Department of Psychiatry, The University of Melbourne, Melbourne, VIC 3000, Australia
Evid Based Complement Alternat Med 2012:809653. 2012..In conclusion, certain lifestyle modifications and some CAMs may provide a beneficial role in the treatment of anxiety disorders...- The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo-controlled, double-blind studyJ Sarris
The University of Melbourne, Department of Psychiatry, 2 Salisbury St, Richmond, Melbourne, Australia
Hum Psychopharmacol 27:262-9. 2012.... - A comparative study of sertraline dosages, plasma concentrations, efficacy and adverse reactions in Chinese versus Caucasian patientsChee Hong Ng
Department of Psychiatry, University of Melbourne, The Melbourne Clinic and St Vincent s Mental Health Service, Richmond, Victoria, Australia
Int Clin Psychopharmacol 21:87-92. 2006..Further studies of the dosages, kinetics and adverse effects of selective serotonin reuptake inhibitors linked with genotyping are necessary... - Serotonin transporter polymorphisms and clinical response to sertraline across ethnicitiesChee Hong Ng
Professorial Unit, The Melbourne Clinic, University of Melbourne, Australia
Prog Neuropsychopharmacol Biol Psychiatry 30:953-7. 2006..Comparison of the subjects with the 5HTTLPR s/s genotype and those with the l/l and l/s genotypes found no significant differences in the HDRS scores, CGI scores, response rates, adverse effects and SERT plasma concentrations at week 6... - Beyond the evidence: is there a place for antidepressant combinations in the pharmacotherapy of depression?Nicholas A Keks
Monash University, Melbourne, Vic
Med J Aust 186:142-4. 2007..There is little evidence to support use of antidepressant combinations. Risk of toxicity and drug interactions mandate that combinations be used as a last resort, and only in specialist settings... - Antipsychotic use in the elderly: what doctors say they do, and what they doJohn Tiller
Albert Road Clinic, The University of Melbourne, Melbourne, Victoria, Australia
Australas J Ageing 27:134-42. 2008..To review psychiatrists' attitudes and actual practice on the use of typical and atypical antipsychotics in the elderly... - The association between depression and isotretinoin use in acneChee Hong Ng
Department of Psychiatry, University of Melbourne, Australia
Aust N Z J Psychiatry 37:78-84. 2003..The purpose of this paper is to highlight this association, examine the possible link and review the clinical implications... - An inter-ethnic comparison study of clozapine dosage, clinical response and plasma levelsChee H Ng
Department of Psychiatry, University of Melbourne, Richmond, Victoria, Australia
Int Clin Psychopharmacol 20:163-8. 2005..Hence, appropriate dose adjustment should be considered in Asian patients receiving maintenance clozapine therapy in clinical practice... - Prospective study of depressive symptoms and quality of life in acne vulgaris patients treated with isotretinoin compared to antibiotic and topical therapyChee H Ng
Department of Psychiatry, The University of Melbourne, The Melbourne Clinic, Melbourne, Victoria, Australia
Australas J Dermatol 43:262-8. 2002..However, because of the study limitations, a larger study is needed to confirm the findings... - Improving collaboration between private psychiatrists, the public mental health sector and general practitioners: evaluation of the Partnership ProjectJane Pirkis
Program Evaluation Unit, School of Population Health, University of Melbourne, Victoria 3010, Australia
Aust N Z J Psychiatry 38:125-34. 2004..The evaluation aimed to describe the impacts and outcomes of these elements... - Public and private psychiatry: can they work together and is it worth the effort?Alison Yung
Department of Psychiatry, University of Melbourne, Parkville Victoria, Australia
Aust N Z J Psychiatry 39:67-73. 2005..It also examined possible barriers to collaboration and some possible solutions to the identified problems... - The emerging role of pharmacogenetics: implications for clinical psychiatryChee Hong Ng
The Melbourne Clinic, Department of Psychiatry, University of Melbourne, Victoria, Australia
Aust N Z J Psychiatry 38:483-9. 2004..This article aims to review the implications of pharmacogenetics for clinical psychiatry; these are discussed in the context of environmental and sociocultural factors... - Audit of antipsychotic prescribing in a private psychiatric hospitalLev Botvinik
Professorial Unit, Melbourne Clinic, Richmond, Vic, Australia
Australas Psychiatry 12:227-33. 2004..Another aim was to compare the findings with other published evidence, and consider the implications of antipsychotic use for current clinical practice in Australia... - Prolactin response to d-fenfluramine in combat-related post-traumatic stress disorderIsaac Schweitzer
The Melbourne Clinic, Department of Psychiatry, University of Melbourne, Richmond, Australia
Int J Neuropsychopharmacol 7:291-8. 2004..To confirm this, further studies involving both healthy and combat-exposed control groups in addition to subjects with PTSD of similar ages are required... - A comparison of propofol and thiopentone use in electroconvulsive therapy: cognitive and efficacy effectsAnna Ingram
Department of Psychology, The University of Melbourne, Australia
J ECT 23:158-62. 2007..The purpose of this study was to compare thiopentone and propofol administration for electroconvulsive therapy (ECT) in terms of associated efficacy and cognitive side effects in the immediate and medium term... - Recent advances in optimizing electroconvulsive therapyColleen K Loo
Black Dog Institute, Hospital Rd, Prince of Wales Hospital, Barker St, Sydney, New South Wales 2031, Australia
Aust N Z J Psychiatry 40:632-8. 2006..Clinical practice should be guided by a careful appraisal of the available evidence for alternative approaches in ECT technique... - Blunted growth hormone response to clonidine in post-traumatic stress disorderPhilip Morris
Department of Psychiatry, University of Queensland, Brisbane, Australia
Psychoneuroendocrinology 29:269-78. 2004..This suggests that post-synaptic alpha2-receptors are subsensitive. This finding is consistent with other studies showing increased noradrenergic activity in PTSD... - Blunted prolactin response to D-fenfluramine in post-stroke major depressionPhilip Morris
Gold Coast District Health Services, Integrated Mental Health Service, PO Box 554, Southport, Queensland 4215, Australia
J Affect Disord 76:273-8. 2003..This study investigated whether patients suffering from post-stroke depressive disorder had a similar disturbance in central serotonergic function to that described in non-brain injured depressed patients... - Cognitive side effects of brief pulse electroconvulsive therapy: a reviewAnna Ingram
Department of Psychology, University of Melbourne, Victoria, Australia
J ECT 24:3-9. 2008..The following article presents an overview of what is currently known about the pattern and recovery of cognitive side effects of ECT. Controversies within the literature and areas requiring further research are highlighted...